Comera Life Sciences Holdings, Inc. (“Comera” or the “Company”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today...
Comera Life Sciences, Inc. (“Comera”) , which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, and OTR Acquisition Corp. (Nasdaq:...
Comera Life Sciences, Inc. (“Comera” or the “Company”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, and OTR Acquisition...
OTR Acquisition Corp. (Nasdaq: OTRAU) (the “Company”) announced that, commencing December 10, 2020, holders of the units sold in the Company’s initial public offering may elect to separately trade...
OTR Acquisition Corp. (Nasdaq: OTRAU) (“OTR Acquisition Corp.” or the “Company”) today announced the closing of its previously announced initial public offering of 10,000,000 units at a price of...
OTR Acquisition Corp. (Nasdaq: OTRAU) (“OTR Acquisition Corp.” or the “Company”) today announced the pricing of its initial public offering of 10,000,000 units at a price of $10.00 per unit. The...